Huiyan Luo

18PUBLICATIONS
116CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsMedical biotechnology diagnostics (incl. biosensors)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 11, 2026
Circulating tumour DNA to guide rechallenge with cetuximab plus irinotecan in RAS/BRAF wild-type metastatic colorectal cancer: A nonrandomised clinical trial.

|Mar 02, 2026
Longitudinal Plasma Metabolomics Guides Dynamic Risk Assessment and Dietary Modulation for Esophageal Squamous Cell Cancer Chemoimmunotherapy.

Zheng-Yu Qian, Yuqing Deng, Mian Xi

|Dec 01, 2025
Targeted methylation of cg24067911 suppresses colorectal cancer metastasis through BCL6-ATXN1-CDH1 axis.

Lu-Ping Yang, Jia-Qian Huang, Chiu-Wing Yeung

|Oct 30, 2025
The INSPECTOR study: enhanced feasibility for clinical translation of a multi-cancer early detection method based on enzyme-assisted high signal-to-noise ratio sequencing of methylated circulating tumor DNA.

Hui-Yan Luo, Wei Wei, Pansong Li

|Apr 27, 2025
Nuclear mitochondrial acetyl-CoA acetyltransferase 1 orchestrates natural killer cell-dependent antitumor immunity in colorectal cancer.

Chen Wei, Kun Liao, Hao-Jie Chen

|Mar 21, 2025
Safety, Pharmacokinetics, and Pharmacodynamics Evaluation of Ivonescimab, a Novel Bispecific Antibody Targeting PD-1 and VEGF, in Chinese Patients With Advanced Solid Tumors.

Fenghua Wang, Xiaoli Wei, Yulong Zheng

Pageof 3

Frequent Collaborators

14 joint publications

Ruihua Xu

5 joint publications

Zhaolei Zeng

4 joint publications

Qi Zhao

4 joint publications

Zexian Liu